Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection

Completed · Phase 2

Conditions studied: Cervical Cancer, Precancerous Condition

In brief

Precancerous lesions of the cervix occur frequently and are treatable. This justifies a population-based screening program. Following an abnormal Pap smear, patients are referred for a colposcopic exam to confirm the presence/stage of disease and select appropriate treatments. Unfortunately, these approaches do not detect all lesions or can sometimes give 'false positive' results (resulting in overtreatment). We are testing a device called a 'multispectral digital colposcope' to determine whether it is more effective at detecting precancerous cervical lesions than existing tools. Success in our study will make diagnoses more accurate and reduce the costs associated with unnecessary treatments.

Key facts

Study ID
NCT01094132
Run by
British Columbia Cancer Agency
People needed
551
Starts
2012-12-01
Expected to finish
2016-11-09
Last updated by the study team
2019-07-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.